For example, BAF180 is mutated in about 40% of clear cell renal cell carcinomas (ccRCCs), a predominant RCC subtype which accounts for up to 75% of all RCC cases, ranking BAF180 as the second most mutated gene in ccRCC only after VHL [11]. This evidence concerns the gene VHL and renal cell carcinoma.